IKK β Antibody (YA7485)
(Synonyms: IKKB, IKBKB, Inhibitor of nuclear factor kappa-B kinase subunit beta, I-kappa-B-kinase beta, IKK-B, IKK-beta, IkBKB, I-kappa-B kinase 2, Nuclear factor NF-kappa-B inhibitor kinase beta, Serine/threonine protein kinase IKBKB, IKK-2, IKK2, NFKBIKB)IKK β Antibody (YA7485) is a Rabbit-derived and non-conjugated IgG, Kappa monoclonal antibody, targeting to IKK β.
-
Host:
Rabbit
-
Isotype:
IgG
-
Application:
WB, ICC/IF, IP, ELISA
-
Reactivity :
Human, Mouse, Rat
-
Formulation:
Supplied in PBS (pH7.4) containing 50% glycerol, 0.05% Proclin 300, 0.05%BSA
-
Conjugation:
Non-conjugated
Applications
| Application |
WB
WB: Western Blot
|
ICC/IF
ICC/IF: Immunocytochemistry/
Immunofluorescence |
ELISA
ELISA: Enzyme Linked Immunosorbent Assay
|
IP
IP: Immunoprecipitation
|
|---|---|---|---|---|
| Dilution Ratio | 1:2000-1:10000 | 1:200-1:1000 | 1:5000-1:20000 | 1:50-1:200 |
Product Details
IKK β Antibody (YA7485) is a Rabbit-derived and non-conjugated IgG, Kappa monoclonal antibody, targeting to IKK β.
-
Host Rabbit
-
Clonality Monoclonal,Recombinant
-
Species ReactivityHuman, Mouse, Rat
-
Observed Molecular WeightObserved band size: 87 kDaNote: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
-
Calculated Molecular Weight Predicted band size: 87 kDa
The exact sequence is proprietary to MCE.
Endogenous
Protein A affinity purified
Non-conjugated
Unmodified
IgG
Product Properties
-
Appearance
Solution
-
Formulation
Supplied in PBS (pH7.4) containing 50% glycerol, 0.05% Proclin 300, 0.05%BSA
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Verification Images
-
Western blot analysis was performed on extracts from HL60 (lane 1, 20μg), HT22 (lane 2, 20μg), HCT116 (lane 3, 20μg), A594 (lane 4, 20μg), using IKK β Antibody (YA7485). Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST at 25°C for 1hour.The primary antibody (1:2000 dilution) and the loading control antibody (GAPDH, HY-P83944, 1:3000 dilution) were incubated in 5% non-fat milk in TBST for overnight. AF800-conjugated Goat Anti-Rabbit IgG H&L(HY-P810687, 1:1000 dilution) and AF680-conjugated Goat Anti-Mouse IgG H&L(HY-P89186 , 1:10000 dilution) was then applied for 1 hour at 37°C, protect from light.
Background
-
Function
IKK-β (IKBKB) is a catalytic subunit of the IκB kinase (IKK) complex and functions as a central signal integration node that regulates canonical NF-κB signaling, inflammatory responses, cell survival, and immune activation[1]. Mechanistically, activated IKK-β phosphorylates inhibitory IκB proteins, promoting their ubiquitin-dependent degradation and releasing NF-κB transcription factors for nuclear translocation and target gene expression[2]. Through this pathway, IKK-β links extracellular inflammatory stimuli to transcriptional programs that control cytokine production, stress responses, and cellular adaptation[1][3]. In disease contexts, dysregulated IKK-β/NF-κB signaling has been associated with chronic inflammation, cancer, metabolic disorders, cardiovascular disease, and pathogen-driven pathology, making the kinase a widely studied experimental target[1][3]. Compared with the related catalytic isoform IKK-α (CHUK), IKK-β is the predominant kinase mediating canonical NF-κB activation in a NEMO-dependent manner, whereas IKK family members also participate in additional signaling networks beyond classical NF-κB regulation[4]. This functional distinction is important for mechanistic studies aimed at dissecting pathway-specific signaling outputs and inflammatory phenotypes[4]. For experimental applications, pharmacological or genetic inhibition of IKK-β is commonly used to suppress NF-κB activation and evaluate the contribution of inflammatory signaling to disease models, while the expanding spectrum of IKK substrates continues to inform the interpretation of inhibitor-based studies[3][4].
-
Subcellular Localization
Cytoplasm,Nucleus,Membrane raft
-
Expression
Tissue_Specificity: Highly expressed in heart, placenta, skeletal muscle, kidney, pancreas, spleen, thymus, prostate, testis and peripheral blood -
Isoforms & Post-Translational Modification
O14920 has four isomers: O14920-1: 86564 Da (predicted); O14920-2: 85945 Da (predicted); O14920-3: 29236 Da (predicted); O14920-4: 79509 Da (predicted).
Upon cytokine stimulation, phosphorylated on Ser-177 and Ser-181 by MEKK1 and/or MAP3K14/NIK as well as TBK1 and PRKCZ; which enhances activity (PubMed:10022904, PubMed:16207722)丨(Microbial infection) Acetylation of Thr-180 by Yersinia YopJ prevents phosphorylation and activation, thus blocking the I-kappa-B pathway丨Ubiquitinated丨(Microbial infection) Monoubiquitination by TRIM21 is disrupted by Yersinia YopJ丨Hydroxylated by PHD1/EGLN2, loss of hydroxylation under hypoxic conditions results in activation of NF-kappa-B -
Subunit
Component of the I-kappa-B-kinase (IKK) core complex consisting of CHUK, IKBKB and IKBKG; probably four alpha/CHUK-beta/IKBKB dimers are associated with four gamma/IKBKG subunits (PubMed:32935379)
-
SwissProt ID
-
Synonyms
IKKB, IKBKB, Inhibitor of nuclear factor kappa-B kinase subunit beta, I-kappa-B-kinase beta, IKK-B, IKK-beta, IkBKB, I-kappa-B kinase 2, Nuclear factor NF-kappa-B inhibitor kinase beta, Serine/threonine protein kinase IKBKB, IKK-2, IKK2, NFKBIKB
Documentation
References
[1]. Zhang J, et al. IκB kinase β (IKKβ): Structure, transduction mechanism, biological function, and discovery of its inhibitors. Int J Biol Sci. 2023 Aug 6;19(13):4181-4203. [Content Brief]
[2]. IKK-β gene information from NCBI.
[3]. Hinz M. The IκB kinase complex in NF-κB regulation and beyond. EMBO Rep. 2014 Jan;15(1):46-61. [Content Brief]
[4]. Antonia RJ, et al. Expanding the View of IKK: New Substrates and New Biology. Trends Cell Biol. 2021 Mar;31(3):166-178. [Content Brief]